Skip to main content
Log in

Cosmetic neurology: the role of healthcare professionals

  • Short Communication
  • Published:
Medicine, Health Care and Philosophy Aims and scope Submit manuscript

Abstract

In an age of modern technology and an increasing movement towards a 24-h working culture, life for many is becoming more stressful and demanding. To help juggle these work commitments and an active social life, nootropic medication, (the so-called ‘smart pills’) have become a growing part of some people’s lives. Users claim that these drugs allow them to reach their maximal potential by becoming more efficient, smarter and requiring less sleep. The use of these medications and the role of health professionals in their distribution raises many ethical questions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • British Medical Association, BMA. (2007). Boosting your brainpower: Ethical aspects of cognitive enhancements. London, UK: British Medical Association.

  • Caldwell, J.A., J.L. Caldwell, N.K. Smythe, and K.K. Hall. 2000. A double-blind, placebo-controlled investigation of the efficacy of modafinil for sustaining the alertness and performance of aviators: A helicopter simulator study. Psychopharmacology (Berl) 150: 272–282.

    Article  CAS  Google Scholar 

  • Chatterjee, A. 2004. Cosmetic neurology: The controversy over enhancing movement, mentation, and mood. Neurology 63: 968–974.

    Article  PubMed  Google Scholar 

  • CMA. 1995. The role of physicians in prevention and health promotion. Canadian Medical Association. Canadian Medical Association Journal (CMAJ) 153: 208A–208D.

    Google Scholar 

  • Larriviere, D., M. Williams, M. Rizzo, and R.J. Bonnie. 2009. Responding to requests from adult patients for neuroenhancements: Guidance of the Ethics, Law and Humanities Committee. Neurology 73: 1406–1412. doi:10.1212/WNL.0b013e3181beecfe.

    Article  PubMed Central  PubMed  Google Scholar 

  • Repantis, D., O. Laisney, and I. Heuser. 2010a. Acetylcholinesterase inhibitors and memantine for neuroenhancement in healthy individuals: A systematic review. Pharmacological Research the Official Journal of the Italian Pharmacological Society 61: 473–481.

    Article  PubMed  CAS  Google Scholar 

  • Repantis, D., P. Schlattmann, O. Laisney, and I. Heuser. 2010b. Modafinil and methylphenidate for neuroenhancement in healthy individuals: A systematic review. Pharmacological Research the Official Journal of the Italian Pharmacological Society 62: 187–206.

    Article  PubMed  CAS  Google Scholar 

  • Repantis, D., P. Schlattmann, O. Laisney, and I. Heuser. 2008. Antidepressants for neuroenhancement in healthy individuals: A systematic review. Poiesis Praxis 6: 139–174. doi:10.1007/s10202-008-0060-4.

    Article  Google Scholar 

  • Talbot, M. (2009) Brain gain: The underworld of neuroenhancing drugs. The New Yorker. http://www.newyorker.com/reporting/2009/04/27/090427fa_fact_talbot. Accessed June 2013.

  • Turner, D.C., T.W. Robbins, L. Clark, et al. 2003. Cognitive enhancing effects of modafinil in healthy volunteers. Psychopharmacology (Berl) 165: 260–269.

    CAS  Google Scholar 

  • Yesavage, J.A., M.S. Mumenthaler, J.L. Taylor, et al. 2002. Donepezil and flight simulator performance: Effects on retention of complex skills. Neurology 59: 721.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kinan Muhammed.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Muhammed, K. Cosmetic neurology: the role of healthcare professionals. Med Health Care and Philos 17, 239–240 (2014). https://doi.org/10.1007/s11019-013-9497-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11019-013-9497-x

Keywords

Navigation